Inventiva (IVEVF) Cash from Operations (2019 - 2025)
Inventiva (IVEVF) posted Cash from Operations of $121.6 million for Q2 2025, up 333.64% on a QoQ basis from -$52.1 million in Q2 2024, and up 333.64% year-over-year from $28.0 million in Q2 2024.
Analysis
Inventiva (IVEVF) Cash from Operations (2019 - 2025) Analysis & Trends
Inventiva has reported Cash from Operations for 6 years, with the latest figure at $121.6 million in Q2 2025.
- On a quarterly basis, Cash from Operations rose 333.64% year-over-year to $121.6 million in Q2 2025; TTM through Jun 2025 was $15.5 million, a 112.0% increase from a year earlier, with the FY2025 full-year figure at -$122.1 million, down 32.96% from the prior year.
- Cash from Operations was $121.6 million for Q2 2025 at Inventiva, up from -$52.1 million in the prior quarter.
- The five-year high for Cash from Operations was $121.6 million in Q2 2025, with the low at -$52.1 million in Q2 2024.
- Average Cash from Operations over 4 years is -$4.4 million, with a median of -$22.6 million recorded in 2021.
- The sharpest annual moves came in 2021 and 2025: Cash from Operations tumbled 265.59% in 2021, then surged 333.64% in 2025.
- Over 4 years, Cash from Operations stood at -$22.6 million in 2021, then retreated by 18.15% to -$26.8 million in 2022, then tumbled by 94.6% to -$52.1 million in 2024, then surged by 333.64% to $121.6 million in 2025.
- The last three Cash from Operations figures came in at $121.6 million (Q2 2025), -$52.1 million (Q2 2024), and -$26.8 million (Q4 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.47 Bn | 624.71 Bn | 17.26 Bn | 8.62 Bn |
| 2 | AbbVie | 439.99 Bn | 433.42 Bn | 12.70 Bn | 3.44 Bn |
| 3 | Merck | 365.45 Bn | 358.31 Bn | 12.21 Bn | 5.37 Bn |
| 4 | Novartis Ag | 266.57 Bn | 258.88 Bn | 11.24 Bn | 5.88 Bn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | 835.00 Mn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 3.44 Bn |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - | -387.32 Mn |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | 507.66 Mn |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | 313.60 Mn |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 121.63 Mn |
| Jun 30, 2024 | -52.06 Mn |
| Dec 31, 2022 | -26.75 Mn |
| Sep 22, 2022 | -27.36 Mn |
| Dec 31, 2021 | -22.64 Mn |
| Jun 30, 2021 | -14.46 Mn |
| Mar 31, 2021 | -9.39 Mn |
| Dec 31, 2020 | -8.55 Mn |
| Jun 30, 2020 | -3.96 Mn |
| Mar 31, 2020 | -3.95 Mn |
| Dec 31, 2019 | -20.66 Mn |